Donckier V, Wissing M, Bruyns C, Abramowicz D, Lybin M, Vanderhaeghen M L, Goldman M
Laboratoire Pluridisciplinaire de Recherche Expérimentale Biomédicale-Department of Immunology, Hôpital Erasme, Université Libre de Bruxelles, Belgium.
Transplantation. 1995 Jun 15;59(11):1571-6.
Neonatal injection of semiallogeneic cells is known to promote differentiation of donor-specific CD4+ T cells into TH2-like cells in the peripheral lymphoid organs. We reasoned that the propensity of neonatal T cells to synthesize high levels of IL-4 might be involved in this polarization of the alloreactive response and thereby in the development of neonatal transplantation tolerance. First, analysis of cytokine gene expression in lymph nodes after neonatal injection of 10(7) (A/J x BALB/c)F1 cells in BALB/c mice indicated that IL-4 but not IL-2 is rapidly produced by CD4+ cells after allogeneic challenge in vivo. To determine whether the early production of IL-4 was involved in the establishment of allotolerance, BALB/c mice neonatally injected with (A/J x BALB/c)F1 spleen cells received on days 1 and 3 after birth 1 mg of anti-IL-4 mAb (11B11) or the same amount of control mAb. When grafted with A/J skin at 4 weeks, 88% of mice treated with control mAb retained their graft for more than 50 days, whereas rejection occurred within 30 days in 93% of mice treated with anti-IL-4 mAb. Analysis of T cell functions after in vitro restimulation with A/J spleen cells indicated that early IL-4 neutralization did not prevent donor-specific CTL unresponsiveness but allowed the emergence of alloreactive T cells secreting increased levels of IL-2 and IFN-gamma. We conclude that early production of IL-4 is critical for the establishment of neonatal transplantation tolerance in this strain combination, which has disparities across the entire H-2 region.
已知新生期注射半同种异体细胞可促进供体特异性CD4+ T细胞在外周淋巴器官中分化为TH2样细胞。我们推测,新生期T细胞合成高水平IL-4的倾向可能参与了这种同种异体反应的极化,从而参与了新生期移植耐受的形成。首先,对BALB/c小鼠新生期注射10(7)个(A/J×BALB/c)F1细胞后淋巴结中细胞因子基因表达的分析表明,同种异体体内攻击后,CD4+细胞可迅速产生IL-4而非IL-2。为了确定IL-4的早期产生是否参与了同种耐受的建立,新生期注射了(A/J×BALB/c)F1脾细胞的BALB/c小鼠在出生后第1天和第3天接受了1 mg抗IL-4单克隆抗体(11B11)或等量的对照单克隆抗体。4周时移植A/J皮肤,接受对照单克隆抗体治疗的小鼠中有88%的移植物保留超过50天,而接受抗IL-4单克隆抗体治疗的小鼠中有93%在30天内发生排斥反应。用A/J脾细胞体外再刺激后对T细胞功能的分析表明,早期中和IL-4并不能阻止供体特异性CTL无反应性,但允许分泌增加水平的IL-2和IFN-γ的同种反应性T细胞出现。我们得出结论,在这个整个H-2区域存在差异的品系组合中,IL-4的早期产生对于新生期移植耐受的建立至关重要。